Pembanding Perusahaan

Tentang

Immunovant is developing FcRn inhibitors to reduce disease-causing IgG antibodies in autoimmune diseases, with batoclimab in multiple Phase III trials across 6+ indications.

Pendapatan

$0M

Sinyal kesenjangan berita

Tidak ada data kesenjangan berita untuk ticker ini.

Sinyal institusional

Tidak ada sinyal 13F yang tercatat untuk ticker ini.

Pola kaskade

Tidak terdapat dalam pola kaskade yang dilacak.

Hubungan kunci

Tentang

NVIDIA is the dominant designer of graphics processing units and AI accelerator chips. Its data-center GPU monopoly powers the generative-AI revolution, with the H100 and successor Blackwell GPUs serving as the de-facto standard for training and running large language models.

Pendapatan

$130.5B

Sinyal kesenjangan berita

Sinyal institusional

Pola kaskade

Hubungan kunci